Exhibitors & Sponsors
Advanced Accelerator Applications (AAA), a Novartis company, is an innovative radiopharmaceutical company developing, producing, and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy. AAA’s first theragnostic pairing for neuroendocrine tumors includes the diagnostic drugs NETSPOT® and SomaKit TOC®, and therapeutic Lutathera®. Additional theragnostics in development target gastrointestinal stromal tumors and prostate and breast cancer.
At AstraZeneca, we are committed to advancing the science of oncology to deliver life-changing medicines to patients most in need. With a combination-focused pipeline that exploits the power of 4 scientific platforms to help address unmet clinical needs in a host of cancers, we are motivated by a dedication to the scientific delivery and collaboration that will one day help eliminate cancer as a cause of death.
Avella Specialty Pharmacy is a nationally accredited specialty pharmacy, providing individualized care and support to patients since 1996. Avella’s clinical pharmacists and staff members are experts in managing complex disease states like oncology, and providing compassionate care. For more information or to find your dedicated account manager, please visit www.avella.com.
BriovaRx is a leading specialty pharmacy services company dedicated to helping administer and deliver high-quality, cost-effective specialty pharmacy care. BriovaRx combines technology, data, and expertise to provide educational resources, 24/7 pharmacy support, and trusted advice to the individuals, caregivers, and care teams we serve.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are committed to furthering the science and understanding of immuno-oncology through our research and development, as well as by supporting educational activities.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com.
Genomic Health is the world’s leading provider of genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease, one of the greatest issues in healthcare today. For more information on the Oncotype DX® portfolio of breast, colon, and prostate cancer tests, please visit www.OncotypeIQ.com.
GO2 Foundation for Lung Cancer is the place where everyone impacted by lung cancer finds personalized care, powerful connections, and purposeful collaboration—uniting around shared goals to empower people, increase survival, drive innovative research, and transform the future of lung cancer.
HalioDx is an immuno-oncology diagnostic company providing physicians with first-in-class immune-based diagnostic solutions to guide cancer care and contribute to precision medicine in the era of immuno-oncology. Immunoscore® integrates immunohistochemistry combined with sophisticated algorithm and advanced imaging analysis enabling extraction of spatially organized tissue molecular information.
At Janssen Biotech, Inc, we have an urgent commitment to make a difference for cancer patients and those living with autoimmune diseases. Comprised of Janssen Oncology and Janssen Immunology, we deliver transformational biologic medicines to market, and have built a rich legacy of innovative firsts. For more information, visit www.janssen.com.
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and to continue making life better for all those affected by cancer around the world.
The Mesothelioma Center at Asbestos.com is an advocacy group and informational resource dedicated to helping patients and families who have been affected by asbestos-related illness. We are here to help anyone and everyone affected by these diseases, including mesothelioma, lung cancer, and asbestosis. We provide accurate and up-to-date information following a diagnosis.
NeoGenomics specializes in cancer genetics testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA-certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, pharma, and managed care organizations. Visit http://neogenomics.com/ to learn more about our global locations.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of patients. Today, Pfizer Oncology has an industry-leading portfolio of 14 approved cancer medicines across 22 indications, including breast, prostate, kidney, lung, and hematology. We also have 2 oncology biosimilar medicines approved globally and several assets in mid- to late-stage development for the treatment of cancer or as supportive care. Pfizer Oncology is striving to change the trajectory of cancer.
DCISionRT is the result of more than a decade of research and development focused on ductal carcinoma in situ (DCIS). PreludeDx began developing its DCIS test in 2009 after licensing technology from the University of California, San Francisco. DCISionRT was developed specifically to address the challenging decision that patients diagnosed with DCIS and their physicians face when determining treatment following breast-conserving surgery. Now you can make decisions with biological insight not previously available.
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families, and the breast cancer community.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceutical and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
RxVantage is a free tool used by thousands of medical practices. It simplifies finding reps by name, product, or company and allows reps to schedule appointments directly in custom online calendars, saving hours of administrative time that could be devoted to clinical care. RxAssist aggregates patient assistance programs, providing patients with vouchers and grants for products and services.
Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated cancer treatments with convenient access to cutting-edge therapies for those facing cancer in communities. Through its services, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
Sirtex Medical develops and delivers oncology treatments using novel small-particle technology to improve outcomes for patients with cancer. SIR-Spheres® Y-90 resin microspheres target liver tumors with radiation via the hepatic artery during selective internal radiation therapy (SIRT). Recent SIRFLOX study data showed a 7.9-month improvement in progression-free survival in the liver for patients with unresectable metastatic colorectal cancer treated first line with SIR-Spheres Y-90 resin microspheres plus standard chemotherapy.
Sun Pharma has a vision of reaching people and touching lives globally as a leading provider of valued medicines. Our culture is Sunology―a combination of 2 words, sun and ideology is at the core of Sun. Humility, integrity, passion, and innovation together form Sunology. It is a way of life at Sun.
TerSera Therapeutics is a specialty pharmaceutical company headquartered in suburban Chicago with a focus on select therapeutic areas, including oncology. Our mission is to develop products that truly make a difference for patients. Our focus is to bring intelligent solutions to our customers that go beyond the therapy itself to provide improved patient outcomes. We look forward to meeting you!
Our mission is unchanged as we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation, and passion for improving the lives of patients. This singular focus drives our aspiration to discover, develop, and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
Worldwide Breast Cancer is a nonprofit organization dedicated to education and helping navigators communicate clearly through visual discussion tools. You may already know our “Know Your Lemons” campaign, but there is so much more we offer! Come see the latest tool developed with Lillie Shockney.